Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats.
Genetic analysis of the diabetic GK rat has revealed several diabetes susceptibility loci. Congenic strains have been established for the major diabetes locus, Niddm1, by transfer of GK alleles onto the genome of the normoglycemic F344 rat. Niddm1 was dissected into two subloci, physically separated in the congenic strains Niddm1b and Niddm1i, each with at least one disease susceptibility gene. Here we have mapped Niddm1b to 1 cM by genetic and pathophysiological characterization of new congenic substrains for the locus. The gene encoding insulin-degrading enzyme (IDE:) was located to this 1 cM region, and the two amino acid substitutions (H18R and A890V) identified in the GK allele reduced insulin-degrading activity by 31% in transfected cells. However, when the H18R and A890V variants were studied separately, no effects were observed, demonstrating a synergistic effect of the two variants on insulin degradation. No effect on insulin degradation was observed in cell lysates, indicating that the effect is coupled to receptor-mediated internalization of insulin. Congenic rats with the IDE: GK allele displayed post-prandial hyperglycemia, reduced lipogenesis in fat cells, blunted insulin-stimulated glucose transmembrane uptake and reduced insulin degradation in isolated muscle. Analysis of additional rat strains demonstrated that the dysfunctional IDE: allele was unique to GK. These data point to an important role for IDE: in the diabetic phenotype in GK.
Fakhrai-Rad
H
H
Karolinska Institutet, Center for Molecular Medicine, Department of Molecular Medicine, Karolinska Hospital, L602, S-171 76 Stockholm, Sweden.
Nikoshkov
A
A
Kamel
A
A
Fernström
M
M
Zierath
J R
JR
Norgren
S
S
Luthman
H
H
Galli
J
J
D000483:Alleles; D000818:Animals; D020296:Animals, Congenic; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D019556:COS Cells; D002460:Cell Line; D002874:Chromosome Mapping; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006943:Hyperglycemia / Q000235:genetics; D007328:Insulin / Q000378:metabolism*; D050356:Lipid Metabolism; D008297:Male; D018895:Microsatellite Repeats; D008957:Models, Genetic; D009132:Muscles / Q000378:metabolism; D010641:Phenotype; D010957:Plasmids / Q000378:metabolism; D017354:Point Mutation; D051381:Rats; D011916:Rats, Inbred F344; D011922:Rats, Mutant Strains; D017422:Sequence Analysis, DNA; D013997:Time Factors; D014162:Transfection
D001786:Blood Glucose; D007328:Insulin